SG11201907764PA - Methods for screening infections - Google Patents

Methods for screening infections

Info

Publication number
SG11201907764PA
SG11201907764PA SG11201907764PA SG11201907764PA SG11201907764PA SG 11201907764P A SG11201907764P A SG 11201907764PA SG 11201907764P A SG11201907764P A SG 11201907764PA SG 11201907764P A SG11201907764P A SG 11201907764PA SG 11201907764P A SG11201907764P A SG 11201907764PA
Authority
SG
Singapore
Prior art keywords
ramon
international
suite
california
camino
Prior art date
Application number
SG11201907764PA
Inventor
Kathryn Frances Sykes
Robert William Gerwien
Jonathan Scott Melnick
Michael William Rowe
Theodore Michael Tarasow
Original Assignee
Healthtell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthtell Inc filed Critical Healthtell Inc
Publication of SG11201907764PA publication Critical patent/SG11201907764PA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Abstract

Vsiest V..;fus FIG. 00 00 O C (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 30 August 2018 (30.08.2018) WIP0 I PCT ill~~~~~~~~ 0111111010VIIIOH olo moll mollm io 111E1111°111 (10) International Publication Number WO 2018/156808 A3 (51) International Patent Classification: CO7K 9/00 (2006.01) C4OB 40/10 (2006.01) C07K 14/47 (2006.01) G01N 33/564 (2006.01) C4OB 30/04 (2006.01) (21) International Application Number: PCT/US2018/019287 (22) International Filing Date: 22 February 2018 (22.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/462,320 22 February 2017 (22.02.2017) US (71) Applicant: HEALTHTELL INC. [US/US]; 2420 Camino Ramon, Suite 125, San Ramon, California 94583 (US). (72) Inventors: SYKES, Kathryn Frances; 2420 Camino Ra- mon, Suite 125, San Ramon, California 94583 (US). GER- WIEN, Robert William; 2420 Camino Ramon, Suite 125, San Ramon, California 94583 (US). MELNICK, Jonathan Scott; 2420 Camino Ramon, Suite 125, San Ramon, Cal- ifornia 94583 (US). ROWE, Michael William; 2420 Camino Ramon, Suite 125, San Ramon, California 94583 (US). TARASOW, Theodore Michael; 2420 Camino Ra- mon, Suite 125, San Ramon, California 94583 (US). (74) Agent: WESTIN, Lorelei P.; Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto, California 94304 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (54) Title: METHODS FOR SCREENING INFECTIONS (57) : The disclosed embodiments concern non-invasive methods, and apparatus, and systems for identifying infections. The methods are predicated on identifying discriminating peptides present on a peptide array, which are differentially bound by the different mixtures of antibodies present in samples from subjects consequent to an infection relative to binding of mixtures of antibodies present in reference subjects. [Continued on next page] WO 2018/156808 A3 MIDEDIMOMOIDIONDEIDIOMOHIMMOIMMOMOill 00# Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) (88) Date of publication of the international search report: 11 October 2018 (11.10.2018)
SG11201907764PA 2017-02-22 2018-02-22 Methods for screening infections SG11201907764PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762462320P 2017-02-22 2017-02-22
PCT/US2018/019287 WO2018156808A2 (en) 2017-02-22 2018-02-22 Methods for screening infections

Publications (1)

Publication Number Publication Date
SG11201907764PA true SG11201907764PA (en) 2019-09-27

Family

ID=63254116

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907764PA SG11201907764PA (en) 2017-02-22 2018-02-22 Methods for screening infections

Country Status (10)

Country Link
US (1) US20200064345A1 (en)
EP (1) EP3585801A4 (en)
JP (1) JP2020511633A (en)
KR (1) KR20190117700A (en)
CN (1) CN110546157A (en)
AU (1) AU2018225170A1 (en)
CA (1) CA3054368A1 (en)
IL (1) IL268849A (en)
SG (1) SG11201907764PA (en)
WO (1) WO2018156808A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3472181A4 (en) 2016-06-20 2020-05-13 Healthtell Inc. Methods for diagnosis and treatment of autoimmune diseases
EP3472201A4 (en) 2016-06-20 2020-05-13 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
EP3538893A4 (en) 2016-11-11 2020-09-23 Healthtell Inc. Methods for identifying candidate biomarkers
JP2023516806A (en) * 2020-03-11 2023-04-20 エニジェン カンパニー リミテッド ANTI-DIABETIC AND ANTI-OBESITY COMPOSITIONS CONTAINING NOVEL COMPOUNDS
US20210302427A1 (en) * 2020-03-31 2021-09-30 Shuhari Group, LLC Secure Immunity Information Transmission System And Network
US20220139567A1 (en) * 2020-10-30 2022-05-05 The Boeing Company Methods for modeling infectious disease test performance as a function of specific, individual disease timelines
EP4039263A1 (en) * 2021-02-04 2022-08-10 Medivis S.r.l. Formulation for the treatment of asthenopia
AU2022316237A1 (en) * 2021-07-23 2024-02-01 Lateral IP Pty Ltd Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof
CN114496177B (en) * 2022-01-24 2022-09-16 佳木斯大学 Method and system for detecting clinical infection source of infectious department based on big data

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002327958A1 (en) * 2001-09-27 2003-04-07 Oxford Glycosciences (Uk) Ltd A method of protein analysis
US20070003954A1 (en) * 2005-05-12 2007-01-04 The Board Of Regents Of The University Of Texas System Protein and antibody profiling using small molecule microarrays
WO2008066931A2 (en) * 2006-11-29 2008-06-05 Novozymes, Inc. Bacillus licheniformis chromosome
US8545809B2 (en) * 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
CA2755983A1 (en) * 2009-03-23 2010-09-30 The Walter And Eliza Hall Institute Of Medical Research Compounds and methods for modulating an immune response
ES2373262B1 (en) * 2010-07-16 2013-05-06 Consejo Superior De Investigaciones Científicas (Csic) METHOD OF DIFFERENTIAL DIAGNOSIS OF CHAGAS DISEASE.
WO2013120499A1 (en) * 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
EP2867662B1 (en) * 2012-06-27 2021-01-06 Siscapa Assay Technologies, Inc. Multipurpose mass spectrometric assay panels for peptides
US20150119289A1 (en) * 2012-10-24 2015-04-30 Medeolinx, LLC Methods to determine candidate biomarker panels for a phenotypic condition of interest
US9970932B2 (en) * 2013-03-15 2018-05-15 Arizona Board Of Regents On Behalf Of Arizona State University Non-covalent patterned chemical features and use thereof in MALDI-based quality control

Also Published As

Publication number Publication date
US20200064345A1 (en) 2020-02-27
WO2018156808A3 (en) 2018-10-11
EP3585801A4 (en) 2021-05-19
CN110546157A (en) 2019-12-06
CA3054368A1 (en) 2018-08-30
AU2018225170A1 (en) 2019-10-03
IL268849A (en) 2019-10-31
KR20190117700A (en) 2019-10-16
WO2018156808A2 (en) 2018-08-30
JP2020511633A (en) 2020-04-16
EP3585801A2 (en) 2020-01-01

Similar Documents

Publication Publication Date Title
SG11201907764PA (en) Methods for screening infections
SG11201903519UA (en) Methods and systems for barcoding nucleic acid molecules from individual cells or cell populations
SG11201906200WA (en) Nucleic acid-polypeptide compositions and methods of inducing exon skipping
SG11201908489XA (en) De novo synthesized combinatorial nucleic acid libraries
SG11201905243YA (en) Bilateral filters in video coding with reduced complexity
SG11201804178YA (en) Pd1 and/or lag3 binders
SG11201901180WA (en) Systems and methods for providing identity assurance for decentralized applications
SG11201808196UA (en) Neoantigens and methods of their use
SG11201807784SA (en) 3-desoxy derivative and pharmaceutical compositions thereof
SG11201907668PA (en) Segment types as delimiters and addressable resource identifiers
SG11202000330XA (en) Concept for generating an enhanced sound field description or a modified sound field description using a multi-point sound field description
SG11201900201YA (en) Methods for quantitating individual antibodies from a mixture
SG11201906341XA (en) Improved serum albumin binders
SG11201811025VA (en) Systems and methods for automated annotation and screening of biological sequences
SG11201908478SA (en) Sterilisation method
SG11201900442PA (en) Sorting of t lymphocytes in a microfluidic device
SG11201907383QA (en) Systems and methods for vehicle sharing service
SG11201908847TA (en) Apparatuses, systems and methods for imaging flow cytometry
SG11201908326YA (en) Methods of treating neurodegenerative diseases
SG11201906717SA (en) Methods and systems for associating physical and genetic properties of biological particles
SG11201810525XA (en) Anti-gitr antibodies and uses thereof
SG11202000444PA (en) Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets
SG11201901228QA (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
SG11201810604QA (en) Full scale process for preparing polymer powders
SG11201907927SA (en) Binding molecules that specifically bind to tau